As the nuclear receptor FXR regulates bile acid metabolism and may attenuate intestinal inflammation, control of this receptor signaling is expected to be a potentially effective treatment for IBD as well as a preventive approach for IBD-associated CRC. This evidence concerns the gene NR1H4 and inflammatory bowel disease.